4C7T

Focal Adhesion Kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor

• PDB DOI:  https://doi.org/10.2210/pdb4C7T/pdb

• Classification: TRANSFERASE
• Organism(s): Gallus gallus
• Expression System: Trichoplusia ni
• Mutation(s): No 


• Deposited: 2013-09-25 Released: 2014-04-02 
• Deposition Author(s): Le Coq, J., Lietha, D.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.05 Å
• R-Value Free: 0.246 
• R-Value Work: 0.219 
• R-Value Observed: 0.220 

Literature

Inhibition of Both Focal Adhesion Kinase and Fibroblast Growth Factor Receptor 2 Pathways Induces Anti-Tumor and Anti-Angiogenic Activities.

Dao, P., Jarray, R., Smith, N., Lepelletier, Y., Le Coq, J., Lietha, D., Hadj-Slimane, R., Herbeuval, J.P., Garbay, C., Raynaud, F., Chen, H.

(2014) Cancer Lett 348: 88

• PubMed: 24657306 
• DOI: https://doi.org/10.1016/j.canlet.2014.03.007
• Primary Citation of Related Structures:  
  4C7T


• PubMed Abstract: 
  

FAK and FGFR2 signaling pathways play important roles in cancer development, progression and tumor angiogenesis. PHM16 is a novel ATP competitive inhibitor of FAK and FGFR2. To evaluate the therapeutic efficacy of this agent, we examined its anti-angiogenic effect in HUVEC and its anti-tumor effect in different cancer cell lines. We showed PHM16 inhibited endothelial cell viability, adherence and tube formation along with the added ability to induce endothelial cell apoptosis. This compound significantly delayed tumor cell growth. Together, these data showed that inhibition of both FAK and FGFR2 signaling pathways can enhance anti-tumor and anti-angiogenic activities.

---

Organizational Affiliation: 

CNRS, UMR8601, Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, CBNIT, Université Paris Descartes, PRES Sorbonne Paris Cité, UFR Biomédicale, 45 rue des Saints-Pères, 75270 Paris Cedex 06, France; School of Chemical Engineering and Light Industry, Guangdong University of Technology, No. 100 Waihuan Xi Road, Education Mega Center, Guangzhou 510006, China. Electronic address: [e-mail].

Biological Assembly 1  

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 32.24 kDa 
• Atom Count: 2,180 
• Modelled Residue Count: 259 
• Deposited Residue Count: 276 
• Unique protein chains: 1

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
FOCAL ADHESION KINASE 1	A	276	Gallus gallus	Mutation(s): 0  Gene Names: PTK2, FAK, FAK1 EC: 2.7.10.2
UniProt
Find proteins for Q00944 (Gallus gallus) Explore Q00944  Go to UniProtKB:  Q00944

Small Molecules

Ligands 2 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
5RI	B [auth A]	N-methyl-2-[[4-[(3,4,5-trimethoxyphenyl)amino]-1,3,5-triazin-2-yl]amino]benzamide C20 H22 N6 O4 UQGQBHYGCQYHMP-UHFFFAOYSA-N
SO4	C [auth A]	SULFATE ION O4 S QAOWNCQODCNURD-UHFFFAOYSA-L

Binding Affinity Annotations
ID	Source	Binding Affinity
5RI	BindingDB:  4C7T	IC50: 400 (nM) from 1 assay(s)
	Binding MOAD:  4C7T	IC50: 400 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.05 Å
• R-Value Free: 0.246 
• R-Value Work: 0.219 
• R-Value Observed: 0.220 
• Space Group: P 1 2₁ 1

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 44.37	α = 90
b = 45.28	β = 95.11
c = 66.66	γ = 90

Software Package:

Software Name	Purpose
REFMAC	refinement
XDS	data reduction
XDS	data scaling
PHASER	phasing

Structure Validation

Entry History 

Deposition Data

• Released Date: 2014-04-02 
Deposition Author(s): Le Coq, J., Lietha, D.

Revision History  

• Version 1.0: 2014-04-02
  Type: Initial release
  
• Version 1.1: 2014-04-09
  Changes: Database references
• Version 1.2: 2014-05-28
  Changes: Database references
• Version 1.3: 2019-04-03
  Changes: Data collection, Other, Source and taxonomy